📅 PUBMED DAILY TRIAGE — 2026-10-30 Window: 2026-10-29T09:00:00Z → 2026-10-30T09:00:00Z (CRDT) Topics scanned: 10 | Articles reviewed: 99 | Candidates evaluated: 104 High priority: 7 | Standard: 30 | Low/archive: 0 | Unsolicited finds: 3 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): No high-priority finds today (best candidate scored 6/10).
CBC-based diagnostics and machine learning in hematology
CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 0/10).
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
Early cancer detection (liquid biopsy, ctDNA, cfDNA): No high-priority finds today (best candidate scored 0/10).
AI/ML in clinical diagnostics and imaging
PMID:42956750 · Interpretable deep learning maps spatial morphological phenotypes to HCC and LUAD survival. · 8/10 · The interpretable MorphX pathology model achieved concordance indices of 0.775 to 0.799 and identified reproducible morphology-based survival biomarkers across hepatocellular carcinoma and lung adenocarcinoma cohorts. PMID:42955542 · Graph Neural Network Reveals the Cortical Morphology of Local Brain Aging in Normal Cognition and Alzheimer's Disease. · 8/10 · A graph neural network trained on 14,423 cognitively normal adults mapped local cortical aging and identified biologically plausible, clinically associated patterns in mild cognitive impairment and Alzheimer disease.
Precision oncology and genomic medicine
PMID:42956750 · Interpretable deep learning maps spatial morphological phenotypes to HCC and LUAD survival. · 8/10 · The interpretable MorphX pathology model achieved concordance indices of 0.775 to 0.799 and identified reproducible morphology-based survival biomarkers across hepatocellular carcinoma and lung adenocarcinoma cohorts. PMID:42955557 · Comparative analysis of ctDNA-MRD and MVI in predicting postoperative recurrence of hepatocellular carcinoma: a prospective multicenter cohort study. · 8/10 · Longitudinal ctDNA minimal-residual-disease status outperformed microvascular invasion for predicting recurrence after hepatocellular carcinoma resection, with the combined model reaching AUC values of 0.853 to 0.899.
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
Novel therapeutics: immunotherapy, CAR-T, targeted therapy: No high-priority finds today (best candidate scored 6/10).
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID:42957066 · GLP-1 Receptor Agonists Decrease the Rate of Rupture, Cardiac Events, and Death in Patients with Abdominal Aortic Aneurysms. · 8/10 · In 13,722 matched patients per group, GLP-1 receptor agonist use was associated with fewer abdominal aortic aneurysm ruptures, major cardiovascular events, and deaths over five years. PMID:42956842 · Semaglutide versus other GLP-1 RAs and cardiovascular risk in obesity-related cancer survivors. · 8/10 · Among 918 matched obesity-related cancer survivors with diabetes, semaglutide was associated with a lower five-year major cardiovascular event risk than other GLP-1 receptor agonists. PMID:42955666 · Comparative Effects of Pharmacological Treatment on Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. · 8/10 · Across 20 randomized trials, no drug-level differences were found for cardiovascular or all-cause mortality, while several SGLT2 inhibitors and semaglutide reduced heart-failure hospitalization relative to exenatide.
Aging, longevity, and population health
PMID:42955542 · Graph Neural Network Reveals the Cortical Morphology of Local Brain Aging in Normal Cognition and Alzheimer's Disease. · 8/10 · A graph neural network trained on 14,423 cognitively normal adults mapped local cortical aging and identified biologically plausible, clinically associated patterns in mild cognitive impairment and Alzheimer disease.
Rare diseases with high unmet need
Rare diseases with high unmet need: No high-priority finds today (best candidate scored 7/10).
Sentinel scan (unsolicited finds)
PMID:42954935 · Clinical Practice Guideline: Palliative Care for Children and Adolescents With Cancer. · 8/10 · An S3-level pediatric oncology guideline developed 68 recommendations for early specialized palliative care, advance-care planning, symptom control, and coordinated patient- and family-centered care.
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
PMID:42955814 · Targeting menin dependency in acute leukemias: the role of revumenib in NPM1-mutated and KMT2A/NUP98-rearranged disease. · 6/10 · Treatment Innovation PMID:42957220 · Suspected Donor-derived Myeloid Neoplasia After Allogeneic HSCT: A Case-based Review of Clonal Evolution. · 5/10 · Genomics/Precision Medicine PMID:42957219 · FoxP3+ Regulatory T-Cells in Canine Cutaneous Lymphoma and Their Role in Immune Modulation. · 5/10 · Other PMID:42956951 · Nanozyme-Powered Immunotherapy via Concurrent Niche Disruption and Checkpoint Blockade for Acute Myeloid Leukemia. · 5/10 · Treatment Innovation PMID:42955952 · CSE1L enrichment in pediatric and young adult acute myeloid leukemia reveals a ribosomal export dependency. · 5/10 · Drug Development
CBC-based diagnostics and machine learning in hematology
No retained standard-priority articles.
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
No retained standard-priority articles.
AI/ML in clinical diagnostics and imaging
PMID:42957261 · Definitive Hypofractionated Radiotherapy in Elderly Patients With Non-melanoma Skin Cancer: Predicting Complete Response Using a Machine Learning-based Approach. · 6/10 · Diagnostics PMID:42957403 · The Role of Artificial Intelligence in PET Imaging. · 5/10 · Diagnostics PMID:42955797 · A user-friendly platform for deep-learning-based image enhancement in scanning X-ray microscopy. · 5/10 · Diagnostics
Precision oncology and genomic medicine
PMID:42956745 · Single-cell proteomics of saliva enables noninvasive cell profiling in oral cancer. · 6/10 · Genomics/Precision Medicine PMID:42956530 · Spatial multi-omics and AI for decoding tumor heterogeneity: implications for target discovery and therapy resistance. · 6/10 · Genomics/Precision Medicine PMID:42955439 · Treatment options after tumor resistance: exploiting vulnerabilities from genome to tumor microenvironment. · 6/10 · Treatment Innovation PMID:42955008 · FGFR Alterations in Bladder Cancer-From Molecular Pathogenesis to Precision Oncology. · 6/10 · Genomics/Precision Medicine
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID:42957208 · (18)F-BMS-986192 PET to Predict Durable Response to Nivolumab in NSCLC: A Novel Approach Beyond PD-L1 Immunohistochemistry. · 6/10 · Diagnostics PMID:42956951 · Nanozyme-Powered Immunotherapy via Concurrent Niche Disruption and Checkpoint Blockade for Acute Myeloid Leukemia. · 5/10 · Treatment Innovation PMID:42956744 · Niche-reprogramming CAR T therapy improves skeletal muscle regeneration and function in preclinical murine models of Duchenne muscular dystrophy. · 5/10 · Treatment Innovation PMID:42956743 · KRAS(G12D)-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. · 5/10 · Drug Development PMID:42956578 · Tumor-derived amyloid-β drives TREM2(+) macrophages immunosuppression in cholangiocarcinoma. · 5/10 · Drug Development
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID:42957437 · Early Treatment Trajectory and Long-Term Persistence to Semaglutide for Obesity: A Population-Based Cohort Study. · 7/10 · Public Health PMID:42957436 · SGLT2 Inhibitors and Risk of Postmenopausal Bleeding in Women: An Active-Comparator, New-User Cohort Study. · 6/10 · Public Health PMID:42956048 · Integrative genomic SEM analysis of shared genetic architecture and candidate genes for insulin resistance-related metabolic traits. · 6/10 · Genomics/Precision Medicine PMID:42955528 · Medicare Part D formulary coverage of SGLT2 inhibitors across cardiovascular-kidney-metabolic indications, 2019-2026. · 6/10 · Public Health PMID:42955519 · Comparative adverse-event reporting patterns of semaglutide and tirzepatide: a disproportionality analysis of FAERS. · 5/10 · Public Health
Aging, longevity, and population health
PMID:42955393 · Predictors of Major Incident Fracture During Adulthood: Evidence from the Geelong Osteoporosis Study. · 7/10 · Public Health PMID:42956267 · Real-World Health Monitoring Using Wrist-Worn Wearables in Community-Dwelling Older Adults in China: Mixed Methods Feasibility Study. · 6/10 · Public Health PMID:42955453 · Beyond age prediction: a task-oriented framework for evaluating molecular aging clocks. · 6/10 · Diagnostics PMID:42955214 · Red Light Therapy and Mitochondrial Rejuvenation in Age-Related Disorders. · 5/10 · Prevention PMID:42954650 · Stemonine Alleviates UVB-Induced Keratinocyte Senescence by Activating SIRT3. · 5/10 · Drug Development
Rare diseases with high unmet need
PMID:42956461 · Clinical and sociodemographic characterization of acute hepatic porphyria patients in the first Colombian registry. · 7/10 · Public Health PMID:42955481 · Families caring for children and adolescents with rare disease: a health economic evaluation of face-to-face and online psychosocial support intervention of the randomized controlled CARE-FAM-NET study. · 7/10 · Public Health PMID:42956744 · Niche-reprogramming CAR T therapy improves skeletal muscle regeneration and function in preclinical murine models of Duchenne muscular dystrophy. · 5/10 · Treatment Innovation
Sentinel scan (unsolicited finds)
PMID:42954936 · ANA Testing From Background Prevalence to Pretest Probability: A Recommendation for Routine Practice. · 7/10 · Diagnostics PMID:42957427 · SprintX: mitigating data scarcity in antibody design via synthetic structural prior knowledge dataset. · 5/10 · Drug Development
💡 UNSOLICITED FINDS
PMID:42954935 · Clinical Practice Guideline: Palliative Care for Children and Adolescents With Cancer. · 8/10 · An S3-level pediatric oncology guideline developed 68 recommendations for early specialized palliative care, advance-care planning, symptom control, and coordinated patient- and family-centered care. PMID:42954936 · ANA Testing From Background Prevalence to Pretest Probability: A Recommendation for Routine Practice. · 7/10 · The review recommends ordering antinuclear-antibody testing only when clinical suspicion is well founded and interpreting positive results in context rather than using them for general screening or serial monitoring. PMID:42957427 · SprintX: mitigating data scarcity in antibody design via synthetic structural prior knowledge dataset. · 5/10 · These results support SprintX not as a substitute for experimentally resolved complexes, but as a complementary source of structural prior knowledge for structure-aware antibody modeling.
📊 TODAY'S BREAKDOWN
- By research category: Diagnostics 7 | Drug Development 5 | Genomics/Precision Medicine 7 | Other 1 | Prevention 1 | Public Health 9 | Treatment Innovation 7
- By evidence maturity: Exploratory 21 | Validated 16
- By watchlist topic:
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 15 reviewed / 5 kept / highest 6
- CBC-based diagnostics and machine learning in hematology: 0 reviewed / 0 kept / highest 0
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): 5 reviewed / 0 kept / highest 0
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 5 kept / highest 8
- Precision oncology and genomic medicine: 11 reviewed / 6 kept / highest 8
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 5 kept / highest 6
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 8 kept / highest 8
- Aging, longevity, and population health: 15 reviewed / 6 kept / highest 8
- Rare diseases with high unmet need: 3 reviewed / 3 kept / highest 7
- Sentinel scan (unsolicited finds): 10 reviewed / 3 kept / highest 8
- By source type: peer_reviewed 37 | preprint 0
- Topics with zero 8+ articles this run: Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma); CBC-based diagnostics and machine learning in hematology; Early cancer detection (liquid biopsy, ctDNA, cfDNA); Novel therapeutics: immunotherapy, CAR-T, targeted therapy; Rare diseases with high unmet need
🔧 RUN NOTES
- The CBC/ML hematology primary and required fallback queries both returned zero records.
- Capped searches reviewed at most 15 candidates per watchlist topic and 10 for the sentinel.
- All 99 unique selected PMIDs were reconciled independently in ESummary and EFetch with no missing records.
- CRDT uses calendar-day boundaries; boundary-day records were retained even when their create time preceded the nominal timestamp.
- Letters, comments, editorials, and topic false positives were excluded from the retained scored corpus.
- No full text was reviewed; retained classifications use PubMed metadata and abstracts.
- This rerun regenerated the complete daily corpus and did not send Telegram alerts.